File Download
Supplementary

Conference Paper: Dravet Syndrome-Genetic analysis of SCN1A and PCDH19 mutations for 17 Chinese children

TitleDravet Syndrome-Genetic analysis of SCN1A and PCDH19 mutations for 17 Chinese children
Authors
Issue Date2012
PublisherInternational Society for Autism Research (INSAR).
Citation
The 2012 International Meeting for Autism Research, Toronto, ON., Canada, 17-19 May 2012. In Abstract Book, 2012, p. 129-130 How to Cite?
AbstractBACKGROUND: For Dravet syndrome (DS), 80% had mutation in SCN1A gene, which encoded a voltage-gated sodium channel. Recent study demonstrated that 16% of SCN1A-negative patients had mutations in protocadherin-19 (PCDH19) genes. OBJECTIVES: The present study examined the genetic mutations in Chinese DS children and assesses the relationship between mutation and phenotype. METHODS: DNA of 17 DS in The University of Hong Kong was screened for SCN1A mutation using polymerase chain reaction and direct sequencing. SCN1A-negative female patients were then screened for PCDH19 mutation. RESULTS: For DS, 82% (14/17) had SCN1A mutations- truncating mutations (6), splice site mutations (2) and missense mutations (6). These mutations affected Nav1.1 protein functions by pathogenicity assessments including conservative, SIFT and Align-GVGD analyses. We found a relationship between the type of mutation and the degree of intellectual disability (p<0.05), with truncating/ splice site mutations associated with moderate/ severe mental retardation. At the evolution of the disease, 79% (11/14) of DS patients with SCN1A mutations had features which fit into the diagnostic criteria of autism spectrum disorder (ASD). 57% (8/14) had history of vaccination-induced seizures. One of the two female SCN1A-negative patients had PCDH19 mutation. CONCLUSIONS: High percentage of genetic mutations was identified in our Chinese cohort of Dravet Syndrome. Pathogenicity assessment demonstrated that the mutations were linked to the phenotypes of Dravet syndrome. Our detection of high frequency of ASD (79%) and vaccination-induced encephalopathy (57%) in those DS with SCN1A mutation suggested evaluating ASD with epilepsy or vaccination induced encepalopathic children for any relationship between SCN1A mutations.
DescriptionPoster Session 109 - Genetics and Genomics: no. 109.149
Persistent Identifierhttp://hdl.handle.net/10722/153127

 

DC FieldValueLanguage
dc.contributor.authorWong, VCNen_US
dc.contributor.authorKwong, AKYen_US
dc.contributor.authorFung, CWen_US
dc.date.accessioned2012-07-16T09:57:35Z-
dc.date.available2012-07-16T09:57:35Z-
dc.date.issued2012en_US
dc.identifier.citationThe 2012 International Meeting for Autism Research, Toronto, ON., Canada, 17-19 May 2012. In Abstract Book, 2012, p. 129-130en_US
dc.identifier.urihttp://hdl.handle.net/10722/153127-
dc.descriptionPoster Session 109 - Genetics and Genomics: no. 109.149-
dc.description.abstractBACKGROUND: For Dravet syndrome (DS), 80% had mutation in SCN1A gene, which encoded a voltage-gated sodium channel. Recent study demonstrated that 16% of SCN1A-negative patients had mutations in protocadherin-19 (PCDH19) genes. OBJECTIVES: The present study examined the genetic mutations in Chinese DS children and assesses the relationship between mutation and phenotype. METHODS: DNA of 17 DS in The University of Hong Kong was screened for SCN1A mutation using polymerase chain reaction and direct sequencing. SCN1A-negative female patients were then screened for PCDH19 mutation. RESULTS: For DS, 82% (14/17) had SCN1A mutations- truncating mutations (6), splice site mutations (2) and missense mutations (6). These mutations affected Nav1.1 protein functions by pathogenicity assessments including conservative, SIFT and Align-GVGD analyses. We found a relationship between the type of mutation and the degree of intellectual disability (p<0.05), with truncating/ splice site mutations associated with moderate/ severe mental retardation. At the evolution of the disease, 79% (11/14) of DS patients with SCN1A mutations had features which fit into the diagnostic criteria of autism spectrum disorder (ASD). 57% (8/14) had history of vaccination-induced seizures. One of the two female SCN1A-negative patients had PCDH19 mutation. CONCLUSIONS: High percentage of genetic mutations was identified in our Chinese cohort of Dravet Syndrome. Pathogenicity assessment demonstrated that the mutations were linked to the phenotypes of Dravet syndrome. Our detection of high frequency of ASD (79%) and vaccination-induced encephalopathy (57%) in those DS with SCN1A mutation suggested evaluating ASD with epilepsy or vaccination induced encepalopathic children for any relationship between SCN1A mutations.-
dc.languageengen_US
dc.publisherInternational Society for Autism Research (INSAR).-
dc.relation.ispartofInternational Meeting for Autism Research 2012en_US
dc.titleDravet Syndrome-Genetic analysis of SCN1A and PCDH19 mutations for 17 Chinese childrenen_US
dc.typeConference_Paperen_US
dc.identifier.emailWong, VCN: vcnwong@hku.hken_US
dc.identifier.emailKwong, AKY: kkyanna@hku.hken_US
dc.identifier.emailFung, CW: fcw1209m@hkucc.hku.hken_US
dc.identifier.authorityWong, VCN=rp00334en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros200481en_US
dc.identifier.hkuros200574-
dc.identifier.spage129-
dc.identifier.epage130-
dc.publisher.placeCanada-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats